Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Reexamination Certificate
2008-09-09
2008-09-09
Kemmerer, Elizabeth C. (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
C424S085200, C435S320100, C435S471000, C435S069520
Reexamination Certificate
active
10845632
ABSTRACT:
This invention relates to IL-9 muteins that inhibit the activity of wild-type IL-9, multimers and Fc-fusion constructs of IL-9 proteins, and an efficient method to purify IL-9 proteins produced by eukaryotic cells. Related formulations, dosages and methods of administration thereof for therapeutic purposes are also provided. More particularly, these IL-9 muteins, compositions, and methods provide a treatment option for individuals afflicted with conditions where inhibiting IL-9 mediated immune responses would be beneficial, such as allergy, asthma, chronic obstructive pulmonary disease (emphysema and chronic bronchitis), pulmonary and gastro-intestinal mucus hyperplasia, inflammation, immunological disorders, leukemia, and lymphoma.
REFERENCES:
patent: 5734034 (1998-03-01), Jayasena et al.
patent: 6261559 (2001-07-01), Levitt et al.
patent: 2002/0146391 (2002-10-01), Levitt et al.
James A. Wells, Biochemistry, vol. 29, No. 37, Sep. 18, 1990.
Dong, Qu et al., “IL-9 induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice”,Eur. J. Immunol.vol. 29, pp. 2130-2139, 1999.
Gounni, A.S., et al, “Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils”,Blood, vol. 96, No. 6, pp. 2163-2171, 2000.
Gruss, H., et al, “Interleukin 9 Is Expressed by Primary and Cultured Hodgkin and Reed-Sternberg Cells”,Cancer Research, vol. 52, pp. 1026-1031, 1992.
Kunkel, T.A. et al., “Rapid and Efficient Site-Specific Mutagenesis without Phenotypic Selection”,Methods in Enzymology, vol. 154, pp. 367-382, 1987.
Lemoli, R.M., “Interleukin-9 Stimulates the Proliferation of Human Myeloid Leukemic Cells”,Blood, vol. 87, No. 9, pp. 3852-3859, 1996.
Longphre, M. et al., “Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells”,The Journal of Clinical Investigation, vol. 104, No. 10, pp. 1375-1382, 1999.
Postma, D.S., “Genetic Susceptibility to Asthma—Bronchial Hyperresponsiveness Coinherited with a Major Gene for Atopy”,The New England Journal of Medicine, vol. 333, pp. 894-900, 1995.
Renauld, J. et al., “Interleukin-9 Is a Major Anti-Apoptotic Factor for Thymic Lymphomas”,Blood, vol. 85, No. 5, pp. 1300-1305, 1995.
Ulbrecht, M. et al., “High serum lgE concentrations: Association with HLA-DR and markers on chromosome 5q31 and chromosome 11q13”,J. Allergy Clin Immunol, vol. 99, No. 6, pp. 828-836, 1997.
Uyttenhove, C. et al., “Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity”,Proc. Natl. Acad. Sci., vol. 85, pp. 6934-6938, 1988.
Waldmann, T.A., “T-cell receptors for cytokines: TGargets for immunotherapy of leukemia/lymphoma”,Annuals of Oncology, vol. 11 (Suppl. 1), pp. 101-106, 2000.
Boisvert David C.
Longphre Malinda
Shanafelt Armen B.
Zaremba Sydney Morgan
Aerovance, Inc.
Hamud Fozia M
Kemmerer Elizabeth C.
LandOfFree
Interleukin-9 antagonist muteins and their pharmacological... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Interleukin-9 antagonist muteins and their pharmacological..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interleukin-9 antagonist muteins and their pharmacological... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3951339